A PHASE-I II STUDY OF SDZ PSC-833 (PSC) IN COMBINATION WITH DAUNORUBICIN (D) AND CYTARABINE IN REFRACTORY ACUTE MYELOGENOUS LEUKEMIA (AML)/

LILIEMARK J BJORKHOLM M UDEN AM HAST R PAUL C SIMONSSON B TIDEFELT U JULIUSSON G HEDENUS M EVENSEN S TANGEN JM SJO M NESTHUS I HESTDAL K

J. Liliemark et al., A PHASE-I II STUDY OF SDZ PSC-833 (PSC) IN COMBINATION WITH DAUNORUBICIN (D) AND CYTARABINE IN REFRACTORY ACUTE MYELOGENOUS LEUKEMIA (AML)/, Blood, 88(10), 1996, pp. 854-854

NO

Hematology

Blood → ACNP

00064971

88

10

1996

1

1

854 - 854

ISI

0006-4971(1996)88:10<854:APISOS>2.0.ZU;2-N